isn frontiers logo 01

THIN 1200x168 3 02

February 23

Friday, February 23 Eminence Hall
Nishiki Room
9:10-10:30

Symposium: Cardio-renal syndrome

(Joint with the Japanese Circulation Society)

Chairs: Yoshihiko Saito (Japan), Ginova Nainggolan (Indonesia)

 

Cardiovascular disease and multimorbidity in older people with chronic kidney disease

Speaker: Marcello Tonelli (Canada)

 

Inflammaging and vascular calcification in chronic kidney disease

Speaker: Catherine Shanahan (UK)

 

A heart-brain-kidney network controls adaptation to cardiac stress through tissue macrophage activation

Speaker: Katsuhito Fujiu (Japan)

 

Endothelial cell dysfunction in CKD and CVD

Speaker: Minoru Sato (Japan)

 

Young Investigator Network Session

10:50-12:10

Symposium: Phosphate toxicity and CVD

(Co-sponsored by Kissei Pharmaceutical)

Chairs: Naotake Tsuboi (Japan), Ravi Thadhani (USA)

 

Phosphate and cardiovascular calcification

Speaker: Ziad A. Massy (France)

 

Phosphate binders and outcome

Speaker: Hirotaka Komaba (Japan)

 

Which is bad: FGF23 or phosphate

Speaker: Tamara Isakova (USA)

 

Magnesium as a suppressor of phosphate toxicity

Speaker: Yusuke Sakaguchi (Japan)

 

Symposium: CKD and CVD

(Co-sponsored by Daiichi-Sankyo Co., Ltd.)

Chairs: Kouichi Tamura (Japan), Chin-Wei Yang (Taiwan)

 

Mineral metabolism and cardiovascular disease in CKD

Speaker: John Cunningham (UK)

 

Cardiovascular risk prediction in CKD patients

Speaker: Kunihiro Matsushita (USA)

 

Pathophysiology of cerebro-cardio-renal continuum in patients with chronic kidney disease

Speaker: Naoki Nakagawa (Japan)

 

Vascular calcification and vascular stiffness in CKD

Speaker: Paweena Susantitaphong (Thailand)

 

13:30-14:25

Plenary Lecture

Digital health solutions and new payment models: The transforming of chronic care

Speaker: Lisa Pettigrew (USA)

Chairs: Carol Pollock (Australia), Hidetomo Nakamoto (Japan)

14:40-16:30

14:40-16:00

Symposium: DKD and CVD: Clinical

(Co-sponsored by Boehringer Ingelheim GmbH Co., Ltd. / Eli Lilly KK.)

Chairs: Jun Wada (Japan), Sydney C.W. Tang (Hong Kong)

 

Combating DKD: From pathogenesis to treatment

Speaker: Keizo Kanasaki (Japan)

 

Clinical impact of novel anti-diabetic agents in DKD

Speaker: Per-Henrik Groop (Finland)

 

From bench to bedside in DKD

Speaker: Mark Cooper (Australia)

 

Clinical and genetic approaches to DKD

Speaker: Juliana Chan (Hong Kong)

 

Symposium: Hypoxia biology in kidney disease and CVD

(Joint with the Japanese Society for Dialysis Therapy)

Chairs: Joseph V. Bonventre (USA), Reiko Inagi (Japan)

 

Oxygen biology and the kidney

Speaker:Kai-Uwe Eckardt (Germany)

 

Renal oxygenation on cardiopulmonary bypass and risk of post-operative acute kidney injury

Speaker: Roger Evans (Australia)

 

Novel treatment to activate HIF

Speaker: Tetsuhiro Tanaka (Japan)

 

Renal capillary flow and hypoxia in kidney injury

Speaker: Daisuke Nakano (Japan)